Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows(Unaudited)

v3.25.3
Condensed Consolidated Statements of Cash Flows(Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ (2,217,365) $ 217,709
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 324,606 365,997
Provision for bad debts (1,583) 336,506
Gain on sale of assets (16,613)
Stock based compensation 145,400 47,779
Changes in operating assets and liabilities:    
Accounts receivable 1,218,992 6,738,384
Revenues in excess of billing 4,282,495 836,403
Other current assets (323,491) (222,359)
Accounts payable and accrued expenses 1,176,241 10,546
Unearned revenue 714,879 (2,813,220)
Net cash provided by operating activities 5,303,561 5,517,745
Cash flows from investing activities:    
Purchases of property and equipment (485,281) (100,737)
Sales of property and equipment 16,687
Investment in associates 25,396
Purchase of subsidiary shares (7,895)
Net cash used in investing activities (443,198) (108,632)
Cash flows from financing activities:    
Proceeds from the exercise of stock options and warrants 21,500
Proceeds from exercise of subsidiary options 64,147
Proceeds from bank loans 242,421 250,000
Payments on finance lease obligations and loans - net (115,350) (118,311)
Net cash provided by financing activities 191,218 153,189
Effect of exchange rate changes 281,093 (163,511)
Net increase (decrease) in cash and cash equivalents 5,332,674 5,398,791
Cash and cash equivalents at beginning of the period 17,357,944 19,127,165
Cash and cash equivalents at end of period 22,690,618 24,525,956
Cash paid during the period for:    
Interest 165,954 285,362
Taxes $ 100,011 $ 264,030